Resting Energy Expenditure in Palliative Cancer Patients

NCT ID: NCT06206785

Last Updated: 2025-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-05

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study purpose is to measure REE by indirect calorimetry and to determine limits of agreement with confidence intervals between measured REE and predictive equations for determination of energy requirements in patients with incurable cancer. Clinical factors associated with hyper- and hypometabolism will be elucidated. Data will be obtained from patient journals in combination with measurements of REE and registration of survival. Data will be collected at one timepoint and survival will be monitored prospectively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Cachexia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A verified diagnosis of an incurable malignant disease
* Hospitalized at the Cancer clinic, St. Olavs Hospital
* ≥ 18 years of age
* Able to provide written informed consent
* Able to comply with all study procedures

Exclusion Criteria

* Cognitive impairment
* In need of supplementary oxygen
* Receiving invasive or noninvasive ventilation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Olavs Hospital

OTHER

Sponsor Role collaborator

UiT The Arctic University of Norway

OTHER

Sponsor Role collaborator

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital

Trondheim, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Trude R Balstad, PhD

Role: CONTACT

+4792282665

Marianne Erichsen, M.Sc.

Role: CONTACT

+4740053267

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Trude R Balstad, PhD

Role: primary

+4792282665

Tora Solheim, PhD

Role: backup

+4792049507

Related Links

Access external resources that provide additional context or updates about the study.

https://app.cristin.no/projects/show.jsf?id=2636691

Current Research Information System in Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

622545

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Curatively Intended Thoracic Reirradiation
NCT06950073 NOT_YET_RECRUITING
Neuroendocrine Tumors - Patient Reported Outcomes
NCT05064150 ACTIVE_NOT_RECRUITING